A prospective 10 year follow up study of patients with neurofibromatosis type 1

Archives of Disease in Childhood

Volumn 78, Issue 5, 1998, Pages 408-412

  Cnossen, M H ^a   De Goede Bolder, A ^a   Van Den Broek, K M ^a   Waasdorp, C M E ^a   Oranje, A P ^a   Stroink, H ^a   Simonsz, H J ^a   Van Den Ouweland, A M W ^a   Halley, D J J ^a   Niermeijer, M F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Genetic disorders; Neurofibromatosis type 1

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; NEUROFIBROMATOSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031809010     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.78.5.408     Document Type: Article

References (13)

1. Huson SM, Compston DAS, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989;26:704-11.
2. National Institutes of Health consensus development conference statement: neurofibromatosis. Bethesda, MD, USA July 13-15, 1987. Neurofibromatosis 1988;1:172-8.
3. Riccardi VM. Neurofibromatosis; phenotype, natural history and pathogenesis. 2nd ed. Baltimore: The Johns Hopkins University Press, 1992.
4. Huson SM, Hughes RAC, eds. The neurofibromatoses; a pathogenetic and clinical overview. London: Chapman and Hall, 1994.
5. Cnossen MH, Moons KGM, Garssen MPJ, Pasmans NMT, De Goede-Bolder A, Niermeijer MF. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children younger than 6 years of age and clinically suspected of NF1. J Med Genet. [In press.]
6. Obringer AC, Meadows AT, Zackai EH. The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am J Dis Child 1989;143:717-19.
7. Huson SM, Compston DAS, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II: guidelines for genetic counselling. J Med Genet 1989;26: 712-21.
8. Hofman KJ, Harris EL, Bryan RN, Denckla MB. Neurofibromatosis type 1: the cognitive phenotype. J Pediatr 1994; 124(suppl):1-8.
9. Aron AM, Rubenstein AE, Wallace SA, Halperin JC. Learning disabilities in neurofibromatosis. Neurofibromatosis: a handbook for patients, families and health care professionals. New York: Thieme, 1990.
10. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumours in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 1994;125: 63-6.
11. Cnossen MH, Stam EN, Cooiman CMG, et al. Endocrinological disorders and optic pathway glioma in children with neurofibromatosis type 1. Paediatrics 1997;100:667-70.
12. Listernick R, Charrow J, Greenwald M. Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatr 1992;121:584-7.
13. Cohen ME, Duffner PK. Visual evoked responses in children with and without neurofibromatosis. Child's Brain 1988;10:99-111.